We recommend using a newer internet browser, such as Google Chrome or Microsoft Edge, to optimize your browsing experience.

Skip to main content

Efficacy and Safety of Beclomethasone Dipropionate in Patients 12 Years of Age and Older With Asthma

- Persistent Asthma
- Completed

Study Title: Study to Assess the Efficacy and Safety of Beclomethasone Dipropionate in Adolescent and Adult Patients 12 Years of Age and Older With Persistent Asthma

Teva Identifier: BDB-AS-30039 | 2015-002510-80

ClinicalTrials.gov Identifier: NCT02513160

Study Status: Completed

Trial Condition(s): Persistent Asthma

Interventions: Drug: Beclomethasone Dipropionate 640 | Drug: Placebo | Drug: Beclomethasone dipropionate via 320 mcg BAI | Drug: albuterol/salbutamol | Drug: Beclomethasone dipropionate via 320 mcg MDI

Study Description: Please refer to ClinicalTrials.gov for a description of the trial

Click for participation criteria and map of study locations

Key Participation Requirements

Gender: Female, Male

Age Range: 12 Years and older

Trial Duration: September 30, 2015 - March 31, 2016

Phase: Phase 3

Study Type

Interventional